171 related articles for article (PubMed ID: 2364976)
21. Effect of the thromboxane receptor antagonist SQ 29,548 on myocardial infarct size in dogs.
Grover GJ; Schumacher WA
J Cardiovasc Pharmacol; 1988 Jan; 11(1):29-35. PubMed ID: 2450253
[TBL] [Abstract][Full Text] [Related]
22. Pulmonary vascular effects of prostaglandin D2, but not its systemic vascular or airway effects, are mediated through thromboxane receptor activation.
King LS; Fukushima M; Banerjee M; Kang KH; Newman JH; Biaggioni I
Circ Res; 1991 Feb; 68(2):352-8. PubMed ID: 1825033
[TBL] [Abstract][Full Text] [Related]
23. Nitric oxide regulation of TP receptor-mediated pulmonary vasoconstriction in the anesthetized, open-chest rat.
Valentin JP; Bessac AM; Maffre M; John GW
Eur J Pharmacol; 1996 Dec; 317(2-3):335-42. PubMed ID: 8997619
[TBL] [Abstract][Full Text] [Related]
24. Daltroban blocks thromboxane responses in the pulmonary vascular bed of the cat.
Hood JS; Nossaman BD; Ibrahim IN; McMahon TJ; Babycos CR; Kadowitz PJ
J Appl Physiol (1985); 1992 Jun; 72(6):2305-10. PubMed ID: 1385804
[TBL] [Abstract][Full Text] [Related]
25. The effect of the thromboxane A2 receptor antagonist SQ 29,548 on the severity of pacing-induced ischemia.
Grover GJ; Schumacher WA
Basic Res Cardiol; 1989; 84(1):103-10. PubMed ID: 2522297
[TBL] [Abstract][Full Text] [Related]
26. Constriction of cat coronary arteries by synthetic thromboxane A2 and its antagonism.
Smith JB; Yanagisawa A; Zipkin R; Lefer AM
Prostaglandins; 1987 Jun; 33(6):777-82. PubMed ID: 3671730
[TBL] [Abstract][Full Text] [Related]
27. A renal vasodilator effect of angiotensin II revealed by dual thromboxane inhibition.
Badahman AH; Wilson TW
Can J Physiol Pharmacol; 1994 Jun; 72(6):632-6. PubMed ID: 7954094
[TBL] [Abstract][Full Text] [Related]
28. Analysis of effects of bosentan (Ro 47-0203), a nonpeptide endothelin ETA/ETB receptor antagonist, in the hind-limb vascular bed of the cat.
Champion HC; Estrada LS; Estrada LN; Filep JG; Kadowitz PJ
Can J Physiol Pharmacol; 1998 Feb; 76(2):141-7. PubMed ID: 9635152
[TBL] [Abstract][Full Text] [Related]
29. Influence of prostaglandins on vasoconstrictor responses in the hindquarters vascular bed of the cat.
Lippton HL; Chapnick BM; Kadowitz PJ
Prostaglandins Med; 1981 Feb; 6(2):183-202. PubMed ID: 7244027
[TBL] [Abstract][Full Text] [Related]
30. Prostaglandin I2 mediates contraction and relaxation of vascular smooth muscle.
Williams SP; Dorn GW; Rapoport RM
Am J Physiol; 1994 Aug; 267(2 Pt 2):H796-803. PubMed ID: 8067435
[TBL] [Abstract][Full Text] [Related]
31. Differences in activities of thromboxane A2 receptor antagonists in smooth muscle cells.
Miki I; Kase H; Ishii A
Eur J Pharmacol; 1992 Oct; 227(2):199-204. PubMed ID: 1426029
[TBL] [Abstract][Full Text] [Related]
32. Analysis of thromboxane receptor-mediated responses in the feline pulmonary vascular bed.
Kaye AD; Nossaman BD; Ibrahim IN; DeWitt BJ; Feng CJ; Kadowitz PJ
Crit Care Med; 1995 Jan; 23(1):164-70. PubMed ID: 7528116
[TBL] [Abstract][Full Text] [Related]
33. Methylene blue selectively inhibits pulmonary vasodilator responses in cats.
Hyman AL; Kadowitz PJ; Lippton HL
J Appl Physiol (1985); 1989 Mar; 66(3):1513-7. PubMed ID: 2468643
[TBL] [Abstract][Full Text] [Related]
34. Role of pressor prostanoids in rats with angiotensin II-salt-induced hypertension.
Mistry M; Nasjletti A
Hypertension; 1988 Jun; 11(6 Pt 2):758-62. PubMed ID: 3164706
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of vasoconstrictor responses by prostacyclin (PGI2) in the feline mesenteric vascular bed.
Lippton HL; Chapnick BM; Hyman AL; Kadowitz PJ
Arch Int Pharmacodyn Ther; 1979 Oct; 241(2):214-23. PubMed ID: 393194
[TBL] [Abstract][Full Text] [Related]
36. Nisoldipine inhibits vasoconstrictor responses in the cat pulmonary vascular bed.
Kadowitz PJ; Lippton HL; Bellan JA; Hyman AL
J Appl Physiol (1985); 1989 Jun; 66(6):2885-90. PubMed ID: 2473060
[TBL] [Abstract][Full Text] [Related]
37. Reduced thromboxane receptor affinity and vasoconstrictor responses in placentae from diabetic pregnancies.
Wilkes BM; Mento PF; Hollander AM
Placenta; 1994 Dec; 15(8):845-55. PubMed ID: 7886025
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the responses to serotonin and prostanoids in human umbilical arteries perfused in vitro.
Bjøro K; Stray-Pedersen S
Scand J Clin Lab Invest Suppl; 1986; 184():85-90. PubMed ID: 3155351
[TBL] [Abstract][Full Text] [Related]
39. Endogenous vasoconstrictor prostanoids: role in serotonin and vasopressin-induced coronary vasoconstriction.
Lee SL; Levitsky S; Feinberg H
J Pharmacol Exp Ther; 1991 Jul; 258(1):292-8. PubMed ID: 2072301
[TBL] [Abstract][Full Text] [Related]
40. Endotoxin priming of thromboxane-related vasoconstrictor responses in perfused rabbit lungs.
Steudel W; Krämer HJ; Degner D; Rosseau S; Schütte H; Walmrath D; Seeger W
J Appl Physiol (1985); 1997 Jul; 83(1):18-24. PubMed ID: 9216939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
